Primary Site >> Esophagus Cancer
Gene >> CD8A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Influence of preoperative treatment and surgical operation on immune function of patients with esophageal carcinoma. PMID: 1372377 Ref: Effect of anti-CD3 antibody on the generation of interleukin-2-activated lymphocytes from tumor tissues of gastrointestinal cancer. PMID: 1386555 |
Ref: HLA A2601-restricted CTLs recognize a peptide antigen expressed on squamous cell carcinoma. PMID: 7671230 Ref: [Tumor-rejection antigens expressed on human squamous cell carcinoma]. PMID: 8721083 |
Ref: Prognostic significance of immunological parameters in patients with esophageal cancer. PMID: 8799384 |
Ref: Effects of en bloc esophagectomy on nutritional and immune status in patients with esophageal carcinoma. PMID: 9486779 Ref: The influence of surgical stress on T cells: enhancement of early phase lymphocyte activation. PMID: 9842843 |
Ref: Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor. PMID: 10394145 Ref: Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer. PMID: 10499620 |
Ref: Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus. PMID: 11220746 Ref: Immunohistochemical study of leukocyte infiltration and expression of hsp70 in esophageal squamous cell carcinoma. PMID: 11295085 Ref: Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. PMID: 11358808 |
Ref: Epstein-Barr virus-associated lymphoepithelioma-like carcinoma of the esophagus. PMID: 12733124 Ref: Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. PMID: 14555512 |
Ref: NY-ESO-1 expression and immunogenicity in esophageal cancer. PMID: 15475443 |
Ref: Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. PMID: 15837746 Ref: Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis. PMID: 15844180 Ref: [Perioperative changes of cellular immune response of patients with esophageal carcinoma evaluated through detecting AgNOR content in peripheral blood T lymphocytes and T cell subsets]. PMID: 16004816 |
Ref: Characterization of IL-2-activated TILs and their use in intrapericardial immunotherapy in malignant pericardial effusion. PMID: 16362409 Ref: Lymphocytic esophagitis: a histologic subset of chronic esophagitis. PMID: 16613348 |
Ref: T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein. PMID: 17441676 Ref: [Effect of cellular immune supportive treatment on immunity of esophageal carcinoma patients after modern two-field lymph node dissection]. PMID: 17626759 |
Ref: Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination. PMID: 18729190 |
Ref: Inverse correlation between NKG2D expression on CD8+ T cells and the frequency of CD4+CD25+ regulatory T cells in patients with esophageal cancer. PMID: 18564160 Ref: Identification of a new broad-spectrum CD8+ T cell epitope from over-expressed antigen COX-2 in esophageal carcinoma. PMID: 19423214 Ref: Tumor immune systems in esophageal cancer with special reference to heat-shock protein 70 and humoral immunity. PMID: 19443372 Ref: Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: association with disease progression. PMID: 19492245 Ref: Influence of neoadjuvant radio-chemotherapy on tumor-infiltrating lymphocytes in squamous esophageal cancer. PMID: 19632080 |
Ref: [Effects of different anesthetic and analgesic protocols on cellular immune function and stress hormone level in patients undergoing lobectomy for esophagus cancer]. PMID: 20159701 |
Ref: A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen. PMID: 21448901 Ref: Prognostic significance of heat shock protein 110 expression and T lymphocyte infiltration in esophageal cancer. PMID: 22086686 |
Ref: Effects of an immuno-enhanced diet containing antioxidants in esophageal cancer surgery following neoadjuvant therapy. PMID: 21762279 Ref: The immunological impact of neoadjuvant chemotherapy on the tumor microenvironment of esophageal squamous cell carcinoma. PMID: 21822560 Ref: Downregulation of MUC1 expression and its recognition by CD8(+) T cells on the surface of malignant pleural mesothelioma cells treated with HDACi. PMID: 22144115 |
Ref: Correlation between the CD4+CD25high regulatory T cells and the outcome of chemotherapy in advanced esophageal carcinoma. PMID: 23262265 Ref: Fish oil-supplemented parenteral nutrition in patients following esophageal cancer surgery: effect on inflammation and immune function. PMID: 23368915 Ref: Preventive effect of ulinastatin on postoperative complications, immunosuppression, and recurrence in esophagectomy patients. PMID: 23575450 |
Ref: Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma. PMID: 24249528 Ref: Randomized study of antiinflammatory and immune-modulatory effects of enteral immunonutrition during concurrent chemoradiotherapy for esophageal cancer. PMID: 24274379 Ref: [Effect of early enteral nutrition on immune response and clinical outcomes after esophageal cancer surgery]. PMID: 24760645 Ref: Lymphoepithelioma-like esophageal carcinoma with macroscopic reduction. PMID: 25132923 Ref: Investigation on immune function and chest drainage in patients with thoracic malignancies using the streptococcal agent Sapylin. PMID: 25579549 Ref: [Expression and clinical significance of CCL5 in patients with esophageal carcinoma]. PMID: 25620479 |
Ref: Clinical implications of Fas/Fas ligand expression in patients with esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy. PMID: 25469286 Ref: Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: A double-blind randomized clinical trial. PMID: 25575640 Ref: High infiltration of tumor-associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer. PMID: 25752960 Ref: Esophageal cancer-derived microvesicles induce regulatory B cells. PMID: 26009869 Ref: Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy. PMID: 26369701 Ref: Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients. PMID: 26429981 Ref: Clinicopathological significance of Fas and Fas ligand expressions in esophageal cancer. PMID: 26609492 |
Ref: Comparison of postoperative immune function in patients with thoracic esophageal cancer after video-assisted thoracoscopic surgery or conventional open esophagectomy. PMID: 27174507 Ref: Fast-track surgery improves postoperative clinical recovery and cellular and humoral immunity after esophagectomy for esophageal cancer. PMID: 27401305 Ref: THE EFFECTS OF A SIMPLE METHOD FOR CRYOPRESERVATION AND THAWING PROCEDURES ON CORD BLOOD DERIVED DC-BASED ESOPHAGEAL CARCINOMA VACCINE. PMID: 27925010 |
Ref: Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer. PMID: 28084319 Ref: Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis. PMID: 28408841 Ref: Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping. PMID: 28657901 Ref: Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3. PMID: 28809608 Ref: Effects of preemptive analgesia with flurbiprofen ester on lymphocytes and natural killer cells in patients undergoing esophagectomy: A randomized controlled pilot study. PMID: 28892265 Ref: PD-L1 Expression, Tumor-infiltrating Lymphocytes, and Clinical Outcome in Patients With Surgically Resected Esophageal Cancer. PMID: 29206673 |
Ref: Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis. PMID: 29414812 Ref: Programmed Death Ligand 1: A Step Toward Immunoscore for Esophageal Cancer. PMID: 29859152 Ref: miR-143 Regulates Memory T Cell Differentiation by Reprogramming T Cell Metabolism. PMID: 30150287 Ref: Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer. PMID: 30308614 |